Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT
Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and ...
Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and ...
Physiology-guided complete revascularization reduces ischemic events compared with culprit-only revascularization in myocardial (MI) infarction patients aged 75 years or older ...
A new study from Australia, New Zealand and Germany published in the New England Journal of Medicine raises important questions ...
In a recent study published in the American Journal of Obstetrics and Gynecology, researchers developed a novel contraceptive 'ZB-06' a ...
A new study, led by experts at the University of Nottingham found that the risk of stomach bleeding caused by ...
The U.S. obesity epidemic continues to have profound impacts on individuals’ health and socioeconomic well-being. Hispanic communities—constituting close to 19%...
Read moreBy Michael Alabran, President of PSN Labs Characterizing the risks of medical devices has always been a challenge. Materials are...
Read morePositive mind and social connection key to recovering from cardiovascular disease Supporting the mental health and wellbeing of over 4...
Read moreLimFlow’s ARC arterial catheter (pictured with needle extended) and the mesh V-Ceiver venous catheter The challenges of developing the LimFlow...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.